Two Sigma Investments’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Two Sigma Investments’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,834,011	Closed	-$22.8M	–	3582
2016 Q4	$22.8M	Buy	1,834,011 +449,837	+32%	+$5.42M	0.09%	267
2016 Q3	$18.9M	Buy	+1,384,174	New	+$13.9M	0.07%	326
2015 Q4	–	Sell	-30,458	Closed	-$178K	–	3164
2015 Q3	$178K	Sell	30,458 -673,876	-96%	-$5.19M	﹤0.01%	2003
2015 Q2	$5.83M	Buy	+704,334	New	+$6.23M	0.03%	653
2015 Q1	–	Sell	-52,658	Closed	-$362K	–	3034
2014 Q4	$362K	Buy	+52,658	New	+$329K	﹤0.01%	1861

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Two Sigma Investments's ARIA Position: Q1 2017 in Review

Two Sigma Investments sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 1,834,011 shares — an estimated $22.8M sold.

Two Sigma Investments first reported a position in ARIA in Q4 2014 and held it in 5 quarters. The position peaked at $22.8M in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Two Sigma Investments reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Two Sigma Investments sold 1,834,011 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $22.8M.
Two Sigma Investments first reported a position in Ariad Pharmaceuticals Inc in Q4 2014 and held it in 5 quarters.
Two Sigma Investments's Ariad Pharmaceuticals Inc position peaked at $22.8M in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Two Sigma Investments's 13F filing for Q1 2017, filed 15 May 2017.